D.E. Shaw & Co
ENZN

D.E. Shaw & Co’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History

D.E. Shaw & Co’s Portfolio ENZN Stock Details ENZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-14,073
Closed -$15K – 4457
2014
Q3 		$15K Sell
14,073
-25,238
-64% -$31.2K ﹤0.01% 4049
2014
Q2 		$41K Hold
39,311
– – ﹤0.01% 4113
2014
Q1 		$40K Hold
39,311
– – ﹤0.01% 4208
2013
Q4 		$46K Sell
39,311
-37,549
-49% -$57.8K ﹤0.01% 4399
2013
Q3 		$129K Sell
76,860
-29,596
-28% -$54.8K ﹤0.01% 4165
2013
Q2 		$213K Buy
+106,456
New +$312K ﹤0.01% 3734

Other funds holding ENZN

IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
CSC
Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co's ENZN Position: Q4 2014 in Review

D.E. Shaw & Co sold out of ENZON PHARMACEUTICALS INC (ENZN) in Q4 2014, closing a stake of 14,073 shares — an estimated $15K sold.

D.E. Shaw & Co first reported a position in ENZN in Q2 2013 and held it in 6 quarters. The position peaked at $213K in Q2 2013. 57 funds tracked by Wall St. Rank hold ENZN as of Q4 2014.

  • D.E. Shaw & Co reported no remaining ENZON PHARMACEUTICALS INC position as of Q4 2014 after selling out during the quarter.
  • D.E. Shaw & Co sold 14,073 ENZON PHARMACEUTICALS INC shares in Q4 2014, an estimated $15K.
  • D.E. Shaw & Co first reported a position in ENZON PHARMACEUTICALS INC in Q2 2013 and held it in 6 quarters.
  • D.E. Shaw & Co's ENZON PHARMACEUTICALS INC position peaked at $213K in Q2 2013.
  • 57 funds tracked by Wall St. Rank held ENZON PHARMACEUTICALS INC as of Q4 2014.

Based on D.E. Shaw & Co's 13F filing for Q4 2014, filed 17 Feb 2015.